PH12016501854A1 - A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using - Google Patents

A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using

Info

Publication number
PH12016501854A1
PH12016501854A1 PH12016501854A PH12016501854A PH12016501854A1 PH 12016501854 A1 PH12016501854 A1 PH 12016501854A1 PH 12016501854 A PH12016501854 A PH 12016501854A PH 12016501854 A PH12016501854 A PH 12016501854A PH 12016501854 A1 PH12016501854 A1 PH 12016501854A1
Authority
PH
Philippines
Prior art keywords
prrsv
methods
respiratory syndrome
syndrome virus
porcine reproductive
Prior art date
Application number
PH12016501854A
Other languages
English (en)
Other versions
PH12016501854B1 (en
Inventor
William W Laegreid
Vu Hiep Lai Xuan
Osorio Fernando
Asit K Pattnaik
Ma Fangrui
Original Assignee
Nutech Ventures
William W Laegreid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutech Ventures, William W Laegreid filed Critical Nutech Ventures
Publication of PH12016501854B1 publication Critical patent/PH12016501854B1/en
Publication of PH12016501854A1 publication Critical patent/PH12016501854A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH12016501854A 2014-03-21 2016-09-21 A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using PH12016501854A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461968465P 2014-03-21 2014-03-21
PCT/IB2015/052214 WO2015140774A1 (en) 2014-03-21 2015-03-25 A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using

Publications (2)

Publication Number Publication Date
PH12016501854B1 PH12016501854B1 (en) 2017-01-09
PH12016501854A1 true PH12016501854A1 (en) 2017-01-09

Family

ID=54143830

Family Applications (2)

Application Number Title Priority Date Filing Date
PH12016501854A PH12016501854A1 (en) 2014-03-21 2016-09-21 A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using
PH12020550204A PH12020550204A1 (en) 2014-03-21 2020-04-02 A non-naturally occurring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH12020550204A PH12020550204A1 (en) 2014-03-21 2020-04-02 A non-naturally occurring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using

Country Status (11)

Country Link
US (3) US10072046B2 (enExample)
EP (1) EP3119429A4 (enExample)
JP (1) JP6538071B2 (enExample)
KR (1) KR20170002393A (enExample)
CN (1) CN107635579A (enExample)
CA (1) CA2943478A1 (enExample)
HK (1) HK1247128A1 (enExample)
MX (1) MX378873B (enExample)
PH (2) PH12016501854A1 (enExample)
RU (1) RU2687150C2 (enExample)
WO (1) WO2015140774A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10072046B2 (en) * 2014-03-21 2018-09-11 Nutech Ventures Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using
TWI704225B (zh) 2016-02-18 2020-09-11 美商益農美國公司 豬繁殖與呼吸綜合症疫苗病毒
US20240189418A1 (en) * 2021-03-31 2024-06-13 The Industry & Academic Cooperation In Chungnam National University (Iac) Virus vaccine based on virus surface engineering providing increased immunity
CN118791578B (zh) * 2024-07-29 2024-12-27 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 猪繁殖与呼吸综合征病毒nsp12蛋白的抗原表位、单克隆抗体及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US6380376B1 (en) * 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
AU754938B2 (en) * 1997-05-06 2002-11-28 Boehringer Ingelheim Vetmedica Gmbh PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays
AU4482200A (en) * 1999-04-22 2000-11-10 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
US20020012670A1 (en) * 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
JP2003520601A (ja) * 2000-01-26 2003-07-08 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｐｒｒｓｖの組み換え弱毒化
EP1929047B1 (en) * 2005-08-30 2010-03-17 Board of Regents of the University of Nebraska Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity
US7622254B2 (en) * 2005-11-29 2009-11-24 Iowa State University Research Foundation, Inc. Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
WO2013017568A1 (en) * 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
US9187731B2 (en) * 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
EP2620446A1 (en) * 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
US10072046B2 (en) * 2014-03-21 2018-09-11 Nutech Ventures Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using

Also Published As

Publication number Publication date
HK1247128A1 (zh) 2018-09-21
PH12016501854B1 (en) 2017-01-09
MX378873B (es) 2025-03-11
EP3119429A1 (en) 2017-01-25
CN107635579A (zh) 2018-01-26
US20190048042A1 (en) 2019-02-14
US11136355B2 (en) 2021-10-05
PH12020550204A1 (en) 2021-01-11
RU2016141287A3 (enExample) 2018-06-07
US10738088B2 (en) 2020-08-11
US10072046B2 (en) 2018-09-11
US20200331970A1 (en) 2020-10-22
EP3119429A4 (en) 2018-04-04
KR20170002393A (ko) 2017-01-06
WO2015140774A1 (en) 2015-09-24
JP6538071B2 (ja) 2019-07-03
RU2016141287A (ru) 2018-04-26
RU2687150C2 (ru) 2019-05-07
MX2016012276A (es) 2017-06-12
US20170198016A1 (en) 2017-07-13
CA2943478A1 (en) 2015-09-24
JP2017510276A (ja) 2017-04-13

Similar Documents

Publication Publication Date Title
PH12020551397A1 (en) Cot modulators and methods of use thereof
MX2021006235A (es) Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos.
MX2019007020A (es) Anticuerpos il-11.
MX2021010418A (es) Composiciones que comprenden una caseína y métodos para producir las mismas.
DK3331355T3 (en) Porcine reproductive and respiratory syndrome virus (prrsv)-resistant porcine and cells having modified cd163 genes
MX2019007021A (es) Anticuerpos il-11ra.
PH12016501763B1 (en) Multispecific antibodies
SG10201808259TA (en) Anti-jagged1 antibodies and methods of use
MX2017003131A (es) Metodo para la preparacion de 2-alcoxi ciclohexanol.
EP3122408A4 (en) Pressurizing masks, systems and methods
PH12020550204A1 (en) A non-naturally occurring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using
EP3137145A4 (en) Resuscitation arrangement comprising mask, monitoring arrangements, and digital module detachably arranged as part of the mask
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
TWD170487S (zh) 喉罩氣道
PH12016502002B1 (en) Novel bacteriophage and composition comprising same
CA163260S (en) Refill station for toothcleaning apparatus
MX2023009431A (es) Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio.
WO2016012406A3 (en) Attenuated strain of prrs and potential use in immunising preparations
AU2018253555A1 (en) Process for the preparation of 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one
MX2015009565A (es) Proceso para elaborar derivados de magnolol.
TH1601003651A (th) ไวรัส PRRS แวเรียนท์ โคลน cDNA ของไวรัส PRRS ยุโรป และการใช้ของมัน
IN2015CH04996A (enExample)
TWD170488S (zh) 喉罩氣道
TH1601002390A (th) อุปกรณ์และวิธีการสำหรับการผลิตแก๊สทดแทนแก๊สธรรมชาติ และโครงข่าย ซึ่งประกอบรวมด้วยสิ่งเดียวกัน
TWD175566S (zh) 雪鏡